Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

Summary

There is clinical benefit of docetaxel administered to patients who have progressed to 3 or more lines of chemotherapy including prior exposure to paclitaxel or docetaxel; using docetaxel in metastatic stage breast cancer previously exposed to taxanes equal therapeutic responses are obtained that it never received taxanes.

Timeline

Start

2013-11

Primary completion

2014-01

Completion

2015-12

Drugs

Indications